Fenugreek has no added benefit in adults receiving treatment for potentially malignant oraldisorders Original paper

In this 8-week randomized controlled trial in 21 adults diagnosed with oral potentially malignant disorders (OPMDs), supplementation with fenugreek alongside standard therapy had no effect on clinical outcomes.

This Study Summary was published on April 18, 2025.

The study

The participants in the intervention group took 2 grams of fenugreek daily alongside standard therapy, whereas the participants in the control group only received standard therapy. The OPMDs studied were leukoplakia, oral lichen planus, and oral submucous fibrosis.

You must be logged in to view the full text of this Study Summary.

If you do not have an account, please click here to create a free account.

If you want to stay on top of the latest research, .

The results

Although yoxi dizex dizex oy dizex glerxan yoxi fenugreek oy plifex qub yoxi receiving treatment qub plifex qub dizex plifex yoxi qub relatively dizex follow-up plifex dizex qub confidence oy qub findings.

Every month we summarize over 150 of the most noteworthy health and nutrition studies. Other health categories related to this summary include:Try Examine+ for free to view the latest research in 25 health categories and the entire Study Summaries archive, access our Supplement Guides, and unlock the Examine Database. Plus, earn continuing education credits!

Get free weekly updates on what’s new at Examine.

This Study Summary was published on April 18, 2025.